Wagenlehner
FM
et al. Ceftolozane-tazobactam compared with
levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet. 2015 May 16;385(9981):1949–56.
[PubMed: 25931244]